Cardiology Online

Home

Welcome

Scientific Committees

Final Program 

Final Program (as a pdf)

IAC Awards

IAC Distinguished Fellowships

Timetable

Participant Letter

Program Topics

General Information

Instructions for the Preparation of Posters

Accommodation

Exhibition

Exhibitors

Abstract Guidelines

Contact Us

LONG-TERM SAFETY AND EFFECTIVENESS OF DRUG-ELUTING STENTS IN ONTARIO, CANADA (Invited Lecture)
J.V. Tu, Institute for Clinical Evaluative Sciences, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

LOW LEVEL LASER IRRADIATION: THERAPEUTIC POTENTIAL IN CARDIOVASCULAR PATHOLOGY (Invited Lecture)
S.D. Gertz, L. Gavish, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

INTRACORONARY PRESSURE AND FLOW VELOCITY: MECHANISTIC INSIGHT FROM LOOKING BEYOND MEANS (Invited Lecture)
M. Siebes, C. Kolyva, B.J. Verhoeff, J.J. Piek, J.A. Spaan, Academic Medical Center, Amsterdam, The Netherlands

NEOINTIMA COVERAGE OF DES AND RISK OF STENT THROMBOSIS - ANGIOSCOPIC EVALUATION (Invited Lecture)
Y. Ueda, K. Okada, K. Matsuo, N. Ogasawara, T. Higo, M. Matsui, K. Kodama, Osaka Police Hospital, Osaka, Japan

COMPUTERIZED GRADUAL ANGIOPLASTY – A NEW TECHNIQUE TO IMPROVE OUTCOME OF CORONARY ANGIOPLASTY AND STENTING, RESULTS OF A RANDOMIZED CONTROLLED TRIAL (Invited Lecture)
A.T. Weiss, D. Leibowitz, H. Danenberg, M. Mosseri, I. Katz, B. Varshitzky, H. Nassar, C. Lotan, Hadassah Medical Center, Jerusalem, Israel

HOW TO MAXIMIZE THE BENEFIT OF THE 17-BETA-ESTRADIOL IN VASCULAR HEALING? (Invited Lecture)
J-F. Tanguay, I. Cloutier, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada

CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION. COMPLICATIONS – HOW TO AVOID THEM? (Invited Lecture)
M. Henry, A. Polydorou, I. Henry, Ad Polydorou, M. Hugel, Cabinet de Cardiologie, Nancy Cedex, France

UPDATE ON CORONARY ARTERY BIFURCATION LESIONS CLASSIFICATION AND INTERVENTIONAL TECHNIQUE (Invited Lecture)
M.R. Movahed, University of Arizona, Southern Arizona VA Health Care System, Tucson, AZ, USA

MICRO- AND MACROVASCULAR PROTECTION TO PREVENT NO-REFLOW IN ACUTE PERCUTANEOUS CORONARY INTERVENTIONS (Invited Lecture)
D.J. Jain, Medical clinik II, Universitaetsklinikum Schleswig-Holstein, Luebeck, Germany

PL:08     Plenary Session
ENDOTHELIAL BIOMEDICINE: NEW OPPORTUNITIES FOR DIAGNOSIS AND TREATMENT
Chairpersons:   A.A. Knowlton, Davis, CA, USA
                       T. Malinski, Athens, OH, USA
 

ACE2 IS A NOVEL REGULATOR OF ENDOTHELIAL FUNCTION AND ATHEROSCLEROSIS (Invited Lecture)
S. Verma, University of Toronto, Toronto, ON, Canada

RESTORATION OF ENDOTHELIAL FUNCTION BY STATINS AND BETA-BLOCKERS - A NANOMEDICAL APPROACH (Invited Lecture)
T. Malinski, Ohio University, Athens, OH, USA

THE ROLE OF ENDOTHELIAL PROGENITOR CELLS IN CARDIOVASCULAR DISEASES (Invited Lecture)
D. Tousoulis, Athens University Medical School, Athens, Greece

EPICARDIAL CORONARY ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN A PORCINE MODEL (Invited Lecture)
L.P. Perrault, Montreal Heart Institute, Montreal, QC, Canada

ESTROGEN, HEAT SHOCK PROTEINS AND CARDIOVASCULAR PROTECTION (Invited Lecture)
A.A. Knowlton, J.P. Stice, University of California, Davis, Northern California VA, CA, USA

ENDOTHELIUM, INFLAMMATION, AND VASCULAR AGING (Invited Lecture)
C.F. Sanchez-Ferrer, C. Peiro, L. Rodriguez-Mañas, Universidad Autonoma, Madrid, Spain

CONTRIBUTIONS OF ENDOPLASMIC STRESS (ER) STRESS TO CARDIOVASCULAR DISEASE (Invited Lecture)
R.C. Austin, J.G. Dickhout, B. Hilditch, S. Basseri, S. Lhotak, J. Zhou, McMaster University, Hamilton, ON, Canada

INSULIN RESISTANCE: EFFECTS ON VASCULAR ENDOTHELIAL FUNCTION AND REPAIR (Invited Lecture)
S.B. Wheatcroft, University of Leeds, Leeds, UK

REGULATION OF SUPEROXIDE GENERATION IN VASCULAR CELLS
Y.L. Siow, C.W. Woo, S. Armstrong, G. Pierce, K. O, University of Manitoba, Winnipeg, MB, Canada

S27   Session
ARRHYTHMIAS II: DIAGNOSIS / DRUG THERAPY / ABLATION
Chairpersons:   H. Heidbuchel, Leuven, Belgium
                       M.H. Pitzalis, Greenville, USA
 

PREDICTION OF RESPONSE TO OSTIAL PULMONARY VEIN ISOLATION BY ANALYZING TEMPORAL PATTERNS OF ATRIAL TACHYARRHYTHMIA BURDEN
M. Martinek, J. Aichinger, H.J. Nesser, S. Sarkar, P.D. Ziegler, H. Purerfellner, Elisabethinen University Teaching Hospital, Linz, Austria

POSTPRANDIAL SYMPTOMS AS AN INDICATOR OF OBSTRUCTION AND REDUCED QUALITY OF LIFE IN HYPERTROPHIC CARDIOMYOPATHY
J.C. Adams, K.W. Klarich, S.R. Ommen, R.A. Nishimura, Mayo Clinic, Rochester, MN, USA

OBESITY PROMOTES LEFT VENTRICULAR CONCENTRIC GEOMETRIC REMODELING AND HYPERTROPHY INDEPENDENT OF BLOOD PRESSURE
G.R. Norton, C. Libhaber, O.H.I. Majane, E. Libhaber, M.J. Maseko, M.R. Essop, P. Sareli, A.J. Woodiwiss, University of the Witwatersrand, Johannesburg, South Africa

HIGH RATE OF ESOPHAGEAL ULCERATIONS AFTER ABLATION OF AF IN PATIENTS WITH GENERAL ANAESTHESIA
M. Martinek, G. Bencsik, J. Aichinger, H.J. Nesser, H. Purerfellner, Elisabethinen University Teaching Hospital, Linz, Austria

SYSTOLIC INTRAVENTRICULAR DYSSYNCHRONY IN HYPERTROPHIC CARDIOMYOPATHY: DIFFERENTIATION FROM ATHLETE HEART
A Kondur, A Niraj, L Afonso, Wayne State University, Detroit, MI, USA

THE HAPLOTYPE OF GDF-15 IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSION
X.J. Wang, X. Yang, K. Sun, J.Z. Chen, X.D. Song, H. Wang, Z. Liu, C.X. Wang, C.N. Zhang, R.T. Hui, Peking Union Medical College, Beijing, China

AFRICAN AMERICAN HAS INCREASED PREVALENCE OF SUSPECTED HYPERTROPHIC CARDIOMYOPATHY DETECTED DURING SCREENING ECHOCARDIOGRAPHY
M.R. Movahed, S. Bates, S. Sattur, A. Martinez, Southern Arizona VA Health Care System, University of Arizona, Tucson, AZ, USA

CHAOTIC LEFT VENTRICULAR DIASTOLE IN PULMONARY HYPERTENSION
A. Lopez-Candales, K. Edelman, B. Gulyasy, R. Bazaz, Cardiovascular Institute, University of Pittsburgh, PA, USA

ADIPOSITY IS ASSOCIATED WITH AN ENHANCED IMPACT OF DELETERIOUS HEMODYNAMIC CHANGES ON LEFT VENTRICULAR MASS
G.R. Norton, O.H.I. Majane, E. Libhaber, C. Libhaber, M.J. Maseko, S. Makaula, P. Sareli, A.J. Woodiwiss, University of the Witwatersrand, Johannesburg, South Africa

EXCESSIVE BREATHLESSNESS IN PATIENTS WITH DIASTOLIC HEART FAILURE
K. Witte, A.L. Clark, University of Hull, Kingston upon Hull, UK

PREDICTORS OF SURVIVAL FOR MORE THAN ONE YEAR IN PATIENTS WITH PRIMARY CARDIAC AMYLOIDOSIS
H. Suradi, K. Hamidi Asl, M.K. Das, M. Benson, Indiana University, Indianapolis, IN, USA

PL:09          Plenary Session   
VALVULAR HEART DISEASE / DISEASES OF THE THORACIC AORTA / CARDIAC SURGERY
Chairpersons:  J.S. Borer, New York, NY USA
                      J.A. Elefteriades, New Haven, CT, USA
        

BIOMARKERS FOR EVALUATING VALVULAR DISEASES: RECENT PROGRESS (Invited Lecture)
J.S. Borer, Weill Cornell Medical College, New York, N.Y. USA

A BLOOD TEST FOR THORACIC ANEURYSM (Invited Lecture)
Y. Wang, C.C. Barbacioru, D. Shiffman, S. Balasubramanian, O. Iakoubova, M. Tranquilli, G. Albornoz, J. Blake, R. Samaha, J.A. Elefteriades, Yale University, New Haven, CT, USA

THE CONCEPT OF VALVULO-METABOLIC RISK IN AORTIC VALVE DISEASE (Invited Lecture)
P. Pibarot, Laval University, Quebec, QC, Canada

PERCUTANEOUS AORTIC VALVE IMPLANTATION: STATE OF THE ART (Invited Lecture)
H. Sievert, N Wunderlich, N Majunke, CardioVascular Center, Frankfurt, Germany, Washington Hospital Center, Washington, DC, USA

MITRAL BALLOON VALVULOPLASTY - 18 YEARS FOLLOW-UP: EFFECT OF MBV ON LEFT VENTRICULAR FUNCTION, SEVERE PULMONARY HYPERTENSION AND SEVERE TRICUSPID REGURGITATION (Invited Lecture)
M.E. Fawzy, King Faisal Specialist Hospital and Research Centre, Riyadh, KSA

OBESITY AND OUTCOMES AFTER ISOLATED CARDIAC VALVE SURGERY
M. Alam, S.S. Virani, V. Nambi, V. Lee, M. Elayda, J.M. Wilson, C.M. Ballantyne, Baylor College of Medicine, Houston, TX, USA

PL:10     Plenary Session   
ATHEROGENESIS, INFLAMMATION AND OXIDATIVE STRESS
Chairpersons:  N.S. Dhalla, Winnipeg, MB, Canada
                      P.R. Liebson, Chicago, IL, USA
 

NOXES, OXIDATIVE STRESS AND VASCULAR (PATHO) BIOLOGY (Invited Lecture)
R. Touyz, University of Ottawa, Ottawa ON, Canada

DRUGS PREVENTING VASCULAR OXIDATIVE STRESS: RECIPROCAL REGULATION OF PRO- AND ANTIOXIDATIVE ENZYME SYSTEMS (Invited Lecture)
U. Forstermann, Johannes Gutenberg University, Mainz, Germany

IMAGING MECHANISMS OF CARDIOVASCULAR CALCIFICATION IN ATHEROSCLEROSIS AND CHRONIC KIDNEY DISEASE (Invited Lecture)
E. Aikawa, Harvard Medical School, Charlestown, MA, USA

CATHEPSIN K PARTICIPATES IN ADIPOGENESIS AND BODY WEIGHT GAIN VIA FIBRONECTIN DEGRADATION (Invited Lecture)
M. Yang, J. Sun, J. Liu, M. Guerre-Millo, K. Clement, B.D. Gelb, G-P. Shi, Harvard Medical School, Boston, MA, USA

OXIDATIVE STRESS & ATHEROGENESIS - THE ROLE OF DRUGS WITH ANTIOXIDANT CAPACITY (Invited Lecture)
J.W. Chen, S.J. Lin, National Yang-Ming University, Taipei Veterans General Hospital, Taipei, Taiwan

INFLAMMATION IN DIABETIC VASCULAR DISEASE: THE ROLE OF HYPERGLYCEMIA (Invited Lecture)
C. Peiro, C.F. Sanchez-Ferrer, Universidad Autonoma de Madrid, Madrid, Spain

MACROPHAGE ACTIVATION AND ATHEROGENESIS: BASIC BIOLOGY AND MOLECULAR IMAGING (Invited Lecture)
M. Aikawa, Harvard Medical School, Boston, MA, USA

S29     Session
NEW INSIGHTS INTO THE PATHOGENESIS AND MANAGEMENT OF HEART FAILURE, PULMONARY CIRCULATION ASPECTS
Chairperson:   M.R. Johnson, Madison, WI, USA

IMPACT OF LEFT ATRIAL VOLUME INDEX AND LEFT VENTRICULAR GEOMETRY ON MORTALITY IN 11,039 PATIENTS > 70 YEARS OF AGE WITH NORMAL EJECTION FRACTION
D.A. Patel, C.J. Lavie, Jr., R.V. Milani, S.M. Artham, H.O. Ventura, Ochsner Clinic Foundation, New Orleans, LA, USA

LDL-APHERESIS AND ITS ABILITY TO REDUCE PLASMA LEVELS OF B-TYPE NATRIURETIC PEPTIDE
P.M. Moriarty, R.P. Sosland, C.A. Gibson, J.M. Belmont, University of Kansas Medical Center, KS, USA

DYSPNEA VERSUS FATIGUE: ADDITIONAL PROGNOSTIC INFORMATION FROM SYMPTOMS IN CHRONIC HEART FAILURE?
K. Witte, A.L. Clark, University of Hull, Kingston upon Hull, UK

CYTOPROTECTION WITH AN ADENOSINE A1 RECEPTOR AGONIST COMPARED TO AN A3 AGONIST IN A CARDIOMYOCYTE MODEL OF ISCHEMIA
V. Urmaliya, C.W. Pouton, I.M. Coupar, P.J. Scammells, P.J. White, Monash University, Melbourne, Australia

LOW DOSE TREATMENT OF CALMIDAZOLIUM CHLORIDE (CMZ) PREVENTS AGAINST HIGH-GLUCOSE INDUCED OXIDATIVE AND NITROSATIVE STRESS AND APOPTOTIC CELL DEATH IN RAT VENTRICULAR MYOBLAST H9C2 CELLS
V. Kain, S. Kumar, S.L. Sitaswad, National Centre for Cell Science, Pune, Maharashtra, India

NEUROPROTECTION WITH PROFOUND HYPOTHERMIA TO 10C DURING HYPOTHERMIC CIRCULATORY ARREST (HCA) IN AN ACUTE PORCINE MODEL: MEASURES OF APOTOSIS IN THE PRIMARY CORTEX
H. Koutsogiannidis, O.G. Ananiadou, A.N. Bibou, A. Charchanti, M. Bai, G.E. Drossos, E.O. Johnson, University of Ioannina, Ioannina, Greece

IRON LOADING AND G-CSF SUPPLEMENT INDUCE INFLAMMATION-DEPENDENT CARDIAC THROMBOSIS IN MICE: AN IN VIVO DISEASE MODEL
W.S. Lian, H. Lin, P.C. King, T. Kikuchi, C.F. Cheng, Tzu Chi General Hospital, Taipei Branch and Tzu Chi University, Taipei, Taiwan

PIOGLITAZONE IMPROVE LEFT VENTRICULAR FUNCTION IN EXPERIMENTAL DIABETIC CARDIOMYOPATHY 
S. Kumar, V. Kain, S.L. Sitaswad, National Center for Cell Science, Puna, Maharashtra, India

POLYCATIONIC LIPIDS COMPLEXED WITH A PLASMID DNA ENCODING ENOS WITH AN ALANINE REPLACING A SER AND A CYTOMEGALOVIRUS PROMOTER EXERTED ENHANCED CARDIOVASCULAR BENEFITS IN HEALTHY AND HEART FAILURE ANIMALS
J. Giannios, N. Kolliopoulos, A. Kanelopoulos, N. Alexandropoulos, Erasinio Hospital, Athens, Greece

PLATELET AGGREGATION INHIBITION WITH INCREASING CONCENTRATIONS OF TIROFIBAN N RENAL INSUFFICIENCY
M. Alam, R. Gonzalez, A. Delarosa, H. Dokainish, N.M. Lakkis, Baylor College of Medicine, Houston, TX, USA

NOVEL MECHANISTIC INSIGHTS INTO THE PROGRESSION OF HUMAN ATRIAL FIBRILLATION (Invited Lecture) 
D. Dobrev, Dresden University of Technology, Dresden, Germany

NEW ADVANCES IN ECHOCARDIOGRAPHY IN ATRIAL FIBRILLATION (Invited Lecture)
A.L. Klein, The Cleveland Clinic Foundation, Cleveland, OH, USA

ATRIAL FIBRILLATION: TO ABLATE OR TO ANTICOAGULATE (Invited Lecture)
A. Capucci, D. Aschieri, Hospital Guglielmo da Saliceto, Piacenza, Italy

ACE INHIBITORS, STATINS, ARBS: DO THEY REALLY PREVENT ATRIAL FIBRILLATION? (Invited Lecture)
A.B. Curtis, University of South Florida, Tampa, FL, USA

LONG-TERM OUTCOMES AFTER ABLATION OF ATRIAL FLUTTER: A META-ANALYSIS (Invited Lecture)
M.A. Wood, C.M. Schubert, F.J. Perez, K.A Ellenbogen, Virginia Commonwealth University, Richmond, VA, USA

ASPIRIN COMBINED WITH ORAL ANTICOAGULATION AND DIRECT THROMBIN INHIBITORS (Invited Lecture)
G. Flaker, University of Missouri, Columbia, MO, USA

NEW ORAL ANTICOAGULANTS: THE FUTURE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (Invited Lecture)
J. Weitz, Hendersen Research Center, Hamilton, Ontario, Canada

FREQUENCY MAPPING OF COMPLEX ATRIAL FRACTIONATED ELECTROGRAMS (CAFE) DURING ATRIAL FIBRILLATION (Invited Lecture)
E.P. Gerstenfeld, J.F. Roux, S. Gojraty, C. Liu, R. Bala, M. Hutchinson, S. Dixit, F.E. Marchlinski, Hospital of the University of Pennsylvania, Philadelphia, PA, USA     

EMERGENCE OF CRYOABLATION AS A THERAPY FOR ATRIAL FIBRILLATION (Invited Lecture)
P.G. Guerra, Montreal Heart Institute, Montreal, QC, Canada

RESULTS OF CONCOMITANT INTRAOPERATIVE ABLATION TO TREAT PERMANENT ATRIAL FIBRILLATION (Invited Lecture)
T. Deneke, K. Khargi, P.H. Grewe, T. Lawo, D. Voss, A. Laczkovics, A. Muegge, B. Lemke, M. Fritz, University of Bochum, Bochum, Germany

GIVING RAT POISON TO PATIENTS IS EVEN MORE DANGEROUS THAN PREVIOUSLY THOUGHT: A RE-EXAMINATION OF LONG-TERM WARFARIN THERAPY (Invited Lecture)
P. Whittaker, University of Massachusetts, Worcester, MA, USA   

PL:12      Plenary Session
MODULATION OF ISCHEMIA – REPERFUSION INJURY, NOVEL BIOMARKERS
Chairpersons:   J.G. Filep, Montreal, QC, Canada
                       K. Przyklenk, Detroit, MI, USA
 

MODIFICATION OF THE INFARCT SIZE LIMITING EFFECTS OF STATINS BY ANTIPLATELET DRUGS (Invited Lecture)
Y. Birnbaum, University of Texas, Galveston, TX, USA

MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN THE DIABETIC HEART (Invited Lecture)
K. Przyklenk, Wayne State University School of Medicine, Detroit, MI, USA

CYTOCHROME P450 ENZYMES IN HEART DISEASE (Invited Lecture)
I. Fleming, Klinikum der J.W. Goethe-Universitat, Frankfurt, Germany

THE ROLE OF THE CHEMOKINES IN HEALING MYOCARDIAL INFARCTION (Invited Lecture)
N.G. Frangogiannis, Baylor College of Medicine, Houston, TX, USA

FETAL PROGRAMMING INCREASES CARDIAC SUSCEPTIBILITY TO ISCHEMIA/REPERFUSION INJURY (Invited Lecture)
S.T. Davidge, University of Albert, Edmonton, AB, Canada

NEW PLAQUE BIOMARKERS FOR ATHEROSCLEROTIC DISEASE PROGRESSION: OUTCOME OF THE LONGITUDINAL ATHERO-EXPRESS STUDY (Invited Lecture)
G. Pasterkamp, F. Moll, D. de Kleijn, University Medical Center, Utrecht, The Netherlands

SERUM AMYLOID A: A MARKER AND MEDIATOR OF ACUTE CORONARY SYNDROMES (Invited Lecture)
J.G. Filep, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

CARDIAC BIOMARKERS IN PULMONARY EMBOLISM AND LUNG DISEASE (Invited Lecture)
I. Khan, University of Maryland, Baltimore, MD, USA

S31        Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY/ CONGENITAL HEART DISEASE
 

INTERMEDIATE FOLLOW-UP OF NATIVE AND RECURRENT COARCTATION STENT REPAIR, IS INTEGRATED IMAGING OF THE AORTIC ARCH NECESSARY? A MULTI-INSTITUTIONAL STUDY
G. Srinath, T. Forbes, The Children’s Hospital Michigan, Detroit, MI, USA

A NEW SCORING SYSTEM TO PREDICT INTRAVENOUS IMMUNOGLOBULIN UNRESPONSIVENESS IN PATIENTS WITH KAWASAKI DISEASE
S. Shimoyama, T. Kobayashi, Y. Inoue, K. Takeuchi, T. Kobayashi, Y. Okada, K. Tamura, T. Tomomasa, T. Otani, H. Arakawa, A. Morikawa, Gunma University, Maebashi, Gunma, Japan

THE ISSUE OF ATRIAL FIBRILLATION AFTER TRANSCATHETER PATENT FORAMEN OVALE CLOSURE IN ADULTS
G. Bronzetti, C. D'angelo, A. Donti, A. Giardini, L. Salomone, E. Mariucci, G. Boriani, F.M. Picchio, University of Bologna, Bologna,Italy

REMOVAL OF PROSTAGLANDIN E2 INCREASES INTRAOPERATIVE BLOOD PRESSURE DURING MODIFIED ULTRAFILTRATION IN PEDIATRIC CARDIAC SURGERY
S. Takabayashi, H. Shimpo, K. Yokoyama, Y. Mitani, Y. Komada, Mie University, Tsu, Mie, Japan

IS THERE AN OPTIMAL TIME FOR THE COMPLETION OF TOTAL CAVOPULMONARY CONNECTION AFTER BIDIRECTIONAL GLENN ANASTOMOSIS?
N. Mkrtchyan, C. Karapetyan, L. Hakobyan, H. Hovaguimian, K. Kurdov, I. Bakunts Nork Marash Medical Center, Yerevan, Armenia

IMPAIRED LEFT VENTRICULAR GLOBAL AND DIASTOLIC FUNCTION IN CHILDREN WITH END STAGE RENAL DISEASE
S. Aggarwal, , S. Patel, T. Mattoo, R. Valentini, Children's Hospital of Michigan, Detroit, MI, USA

HEMODYNAMIC RECOVERY OF POST-RESUSCITATION TREATMENT WITH N-ACETYLCYSTEINE AND NOS INHIBITOR IN HYPOXIC PIGLETS
T-F. Lee, C. Tymafichuk, P-Y. Cheung, University of Alberta, Edmonton, AB, Canada

MYOCARDIAL PERFORMANCE INDEX - A PRELOAD-INDEPENDENT MEASURE OF LEFT VENTRICULAR GLOBAL FUNCTION
S. Aggarwal, S. Patel, T. Mattoo, R. Valentini, Children's Hospital of Michigan, Detroit, MI, USA

EVOLUTION OF TRANSCATHETER CLOSURE OF PERIMEMBRANOUS VENTRICULAR SEPTAL DEFECTS IN A SINGLE CENTRE 
D.P. Kenny, G.M. Morgan, A. Bajwa, C. Farrow, A.J. Tometzki, R.P. Martin, Bristol Royal Hospital for Children, Bristol, UK

BLOOD GLUCOSE LEVEL NEGATIVELY CORRELATES WITH CEREBRAL OXYGEN SATURATION IN NEONATES AFTER THE NORWOOD PROCEDURE
H. Zhang, M. Merat, H. Holtby, S. Cai, G.S.V. Arsdell, J. Li, University of Toronto, Toronto, Canada

HEPATIC FIBROSIS AND CIRRHOSIS IN THE FONTAN CIRCULATION: A DETAILED MORPHOLOGICAL STUDY
T.J. Kendall, B. Stedman, N. Hacking, M. Haw, J.J. Vettukattill, A.P. Salmon, R. Cope, N. Sheron, J.P. Iredale, G.R. Veldtman, University Hospital of Southampton, Southampton, UK

S32     Session
GENETIC DETERMINANTS OF HEART DISEASE, GENE AND CELL BASED THERAPIES, BASIC RESEARCH
Chairperson:     K.N. Pandey, New Orleans, LA, USA
 

LARGE SCALE SNPS ASSOCIATION STUDY TO IDENTIFY GENES CONFER RISK OF MYOCARDIAL INFARCTION
K. Ozaki, H. Sato, N. Ishii, Y. Ebana,  A. Iida, H. Mizuno, M. Hori, Y. Nakamura, T. Tanaka, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo, Japan

A COMMON VARIANT OF ENOS GENE IS AN INDEPENDENT RISK FACTOR FOR LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION
Y. Xin, X.D. Song, H. Xue, Z. Liu, H. Wang, Y. Shi, Y.Y Bai, C.Y. Fu, W.J. Li, R.T. Hui, Peking Union Medical College, Beijing, China

LEUKOTRIENE C4 SYNTHASE AND RISK FOR ATHEROSCLEROSIS IN THE MUSCATINE COHORT LONGITUDINAL STUDY
D.M. Iovannisci, E.J. Lammer, L. Steiner, S. Cheng, L.T. Mahoney, P.H. Davis, T.L. Burns, Children's Hospital and Research Center Oakland, Oakland, CA, USA

IDENTIFICATION OF MULTIPOTENT MESENCHYMAL PROGENITOR CELLS IN THE PORCINE AORTIC VALVE
J.H. Chen, C.A. Simmons, University of Toronto, Toronto, ON, Canada

DIRECTLY TARGETING MYOCARDIAL FIBROSIS WITH FT011 IMPROVES HEART FUNCTION IN EXPERIMENTAL DIABETIC CARDIAC DISEASE
Y. Zhang, K. Connelly, H. Krum, R.E. Gilbert, D.J. Kelly, University of Melbourne, Melbourne, Australia

CARDIAC DYSTROPHINOPATHIES: PREVALENCE AND PHENOTYPES IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY 
M. Pasotti, M. Diegoli, A. Serio, A. Pilotto, N. Marziliano, M. Grasso, F. Gambarin, E. Porcu, S. Mannarino, E. Arbustini, Centre for Inherited Cardiovascular Diseases, Pavia, Italy

RECENT ADVANCES IN AUTOLOGOUS TISSUE HEART VALVES “BIOVALVES” H: IMPROVED SCAFFOLDS FOR OPTIMAL TISSUE FORMATION AND VALVULAR FUNCTIONS
K. Kanda, K. Hayashida, M. Onoyama, T. Tajikawa, H. Ishida, Y. Yahata, K. Ooba, T. Ooie, Y. Okamoto, Y. Nemoto, H. Ueda, T. Watanabe, M. Yamanami, H. Yaku, Y. Nakayama, Kyoto Prefectural University of Medicine, Kyoto, Japan

DEVELOPMENT OF NEW CORONARY ARTERIES DUE TO ANGIOGENIC NOS3 GENE THERAPY (SV22) CIRCUMVENTS CORONARY ARTERY DISEASE (CAD)
J. Giannios, N. Kolliopoulos, N. Alexandropoulos, A. Kanellopoulos, Erasinio Hospital, Athens, Greece 

PL:13    Plenary Session
NEW CONCEPTS IN TRANSLATIONAL CARDIAC REPAIR AND REGENERATION
Chairpersons:  R.J. Lee, San Francisco, CA, USA
                      H.N. Sabbah, Detroit, MI, USA
 

RECONSTRUCTION OF THE FAILING LEFT VENTRICLE WITH INTRAMYOCARDIAL INJECTIONS OF BIOPOLYMERS (Invited Lecture)
H.N. Sabbah, Henry Ford Hospital, Detroit, MI, USA

MESENCHYMAL STROMAL CELL THERAPY IN HEART DISEASE (Invited Lecture)
J. Kastrup, University Hospital Rigshospitalet, Copenhagen, Denmark

IN SITU TISSUE ENGINEERING FOR THE TREATMENT OF CARDIOMYOPATHY (Invited Lecture)
R.J. Lee, University of California, San Francisco, CA, USA   

THE ROLE OF ENDOTHELIAL PROGENITOR CELLS IN ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE (Invited Lecture)
S-J. Lin, P.H. Huang, J.W. Chen, Taipei Veterans General Hospital, Taipei, Taiwan-R.O.C.

HUMAN SERCA2A CONTROLS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION 
A-M. Lompre, A. Coulombe, S. Lehoux, B. Esposito, F. Atassi, C. Le Feuvre, S. Hatem, R.J. Hajjar, L. Lipskaia, Mount Sinai School of Medicine, New York, NY, USA

THE MOLECULAR REGULATION OF GHRELIN EXPRESSION IN CULTURED CARDIOMYOCYTES  BY CYCLIC MECHANICAL STRETCH (Invited Lecture)
B.W. Wang, Y.C. Liu, H. Chang, K.G. Shyu, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

LIPOSOME MEDIATED VASCULAR ENDOTHELIAL GROWTH FACTOR-165 TRANSFECTION WITH SKELETAL MYOBLAST FOR CARDIAC REPAIR
L. Ye, K.H. Haider, W.B. Esa, R.S. Tan, L.P. Su, P.K. Law, W. Zhang, E.K.W. Sim, National University of Singapore, Singapore

HSPA12B IS A NOVEL ANGIOGENESIS REGULATOR AND PROTECTS AGAINST ISCHEMIA/REPERFUSION INJURY IN A RAT MODEL
Z. Han, R. Steagall, M. Thirunavukkarasu, J. Zhan, N. Maulik,  East Tennessee State University, Johnson City, TN, USA

SUSTAINED REVERSE REMODELING IS OBSERVED UP TO SIX MONTHS AFTER MESENCHYMAL STEM CELLS (MSC) TRANSPLANTATION (Invited Lecture)
E.J. Molina, D. Torres, J. Palma, D. Gupta, J.P. Gaughan, M. Macha, Temple University School of Medicine, Philadelphia, PA, USA

TNF PRE CONDITIONING IS SUPERIOR TO HYPOXIC PRECONDITIONING OF HUMAN STEM CELLS IN ANGIOGENIC GROWTH FACTOR PRODUCTION (Invited Lecture)
P.R. Crisostomo, M. Wang, Y. Wang, T. Lahm, D.R. Meldrum, Indiana University, Indianapolis, IN, USA

FT011 IMPROVES HEART FUNCTION AND PREVENTS FIBROSIS IN EXPERIMENTAL MYOCARDIAL INFARCTION (Invited Lecture)
K. Connelly, Y. Zhang, M. Elsik, H. Krum, R.E. Gilbert, D.J. Kelly, University of Melbourne, Melbourne, Australia

PEPTIDASES DEGRADING CARDIOPROTECTIVE NATRIURETIC PEPTIDES: A NEW TARGET FOR THE TREATMENT OF CARDIOVASCULAR DISEASES? (Invited Lecture)         
T. Walther, Charite-Universitatsmedizin, Berlin, Germany

PL:14    Plenary Session
CARDIOVASCULAR DISEASE IN WOMEN/ EPIDEMIOLOGY/ RISK ASSESSMENT
Chairpersons:
             E.L. Barrett-Connor, San Diego, CA, USA
             V. Bittner, Birmingham, Alabama, USA
 

WOMEN AND HEART DISEASE IN THE POST-WHI ERA (Invited Lecture)
E.L. Barrett-Connor, University of California, San Diego, CA, USA

HEART FAILURE IN WOMEN: REALLY DIFFERENT OR JUST PC? (Invited Lecture)
M.R. Johnson, University of Wisconsin, Madison, WI, USA

DYSLIPIDEMIA IN WOMEN: EPIDEMIOLOGY AND TREATMENT (Invited Lecture)
V. Bittner, University of Alabama at Birmingham, Alabama, USA

INTERMITTENT CLAUDICATION: WALKING DISABILITY OR CARDIOVASCULAR DISEASE?
F. Manfredini, University of Ferrara Medical School, Ferrara, Italy

GENDER DIFFERENCE IN THE DESCRIPTION AND TREATMENT OF ANGINA
J.A. Kempf, M. Good, CV Therapeutics, Palo Alto, CA, USA

S33    Session
NEW APPROACHES TO SURGICAL REVASCULARIZATION / HEART VALVE SURGERY / CARDIAC TRANSPLANTATION
Chairperson:  N.M. Rajamannan, Chicago, IL, USA
 

ROLE OF 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING AFTER HEART TRANSPLANTATION IN PEDIATRIC PATIENTS: PRELIMINARY RESULTS
F.I. Calo Carducci, G. Grutter, U. Giordano, C. Iacoella, F. Parisi, Pediatric Hospital Bambino Gesù, Rome, Italy

ROSS REVERSAL: REIMPLANTATION OF THE PULMONARY AUTOGRAFT INTO THE PULMONARY POSITION
K.M. George, M.J. Flynn, E.R. Nowicki, E.H. Blackstone, G.B. Pettersson, Cleveland Clinic, Cleveland, OH, USA

CAUSE OF ISCHEMIC MITRAL REGURGITATION AFTER CORONARY ARTERY BYPASS GRAFTING
T. Hakala, H Suurmunne, J. Mustonen, J. Kouri, O. Pitkanen, North Karelia Central Hospital, Joensuu, Finland

IMPACT OF FIBRONECTIN AND MYELOPEROXIDASE IN CORONARY ARTERY DISEASE
A Orman, M.N. Akkus ,N. Ercetin, G. Polat, S. Erden, A. Camsari, D. Cicek, V.G. Cin, Mersin University, Mersin, Turkey